Using a special dressing to reduce surgical site infections in vascular surgery
Official title: A Randomised Controlled Trial to Assess the Clinical and Cost Effectiveness of Dialkylcarbamoylchloride (DACC) Coated Post-operative Dressings Versus Standard Care in the Prevention of Surgical Site Infection in Clean or Clean-contaminated, Vascular Surgery.
Run by Hull University Teaching Hospitals NHS Trust · NCT02992951 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing a special dressing made from spider silk to see if it can help prevent infections after lower limb vascular surgery compared to regular dressings.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 718 (estimated) |
| Sponsor | Hull University Teaching Hospitals NHS Trust Government |
| Locations | 1 site (Hull, East Riding Of Yorkshire) |
| Trial ID | NCT02992951 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older undergoing clean or clean-contaminated lower limb vascular surgery.
✕Probably not a fit
Patients undergoing procedures that do not involve lower limb incisions or those on antibiotics for other conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial investigates the effectiveness of a DACC-coated dressing, derived from spider silk, in reducing surgical site infections compared to standard non-coated dressings in patients undergoing lower limb vascular surgery. The study will recruit 718 adult patients across multiple centers in the UK, focusing on those with clean or clean-contaminated wounds closed by primary intention. Participants will be monitored for infection rates post-surgery to assess the dressing's performance. The goal is to provide a cost-effective solution to a significant problem in surgical care.
Why it matters
Potential benefit: If successful, this dressing could significantly reduce the incidence of surgical site infections, improving patient outcomes and reducing healthcare costs.
How similar studies have gone: While the use of DACC-coated dressings is innovative, similar approaches in infection control have shown promise, suggesting potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: In order to be eligible for inclusion in the study the participants must meet the following criteria: * Adults ≥18 yrs undergoing clean or clean-contaminated lower limb vascular surgery, with wounds closed by primary intention. * Able to understand the Patient Information Sheet and supplementary materials and capable and willing to give informed consent and follow the protocol requirements (including attending all follow-up visits and completing written questionnaires). Exclusion Criteria: Patients will not be included in the study if they meet any of the following exclusion criteria: * Patients on antibiotics for other conditions at the time of surgery or in the follow up period. * Patients undergoing any procedure that does not include lower limb incisions. * Allergies to any component of either the DACC-coated dressing or the control dressing. * Inability to give informed consent due to incapacity (as defined by the MCA 2005) * Aged under 18 years at the time of recruitment * Use of investigational drug/device therapy within preceding 4 weeks that may interfere with this study.
Where it's running
-
Academic Vascular Surgery Unit, Vascular Laboratory, Alderson House, Hull Royal Infirmary
Hull, East Riding Of Yorkshire, United Kingdom Recruiting
Study contacts
- Principal investigator: George Smith, M.D — Hull University Teaching Hospitals NHS Trust
- Study coordinator: Ross Lathan, MBChB
- Email: ross.lathan2@nhs.net
- Phone: +44 01482674643
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparing saline irrigation and povidone-iodine for preventing infections in emergency surgeries
This study is testing whether using saline irrigation or a povidone-iodine solution before closing surgical incisions can better prevent infections in patients having emergency surgeries.
-
Comparing zinc oxide and petrolatum for healing surgical scars
This study is testing whether zinc oxide ointment works better than petrolatum for healing and reducing scars after skin surgery.
-
Safety-zone for cheek-access mandibular fracture fixation to protect facial nerve
This study tests whether using a defined facial-safety zone during transbuccal access for fixing mandibular fractures helps protect the facial nerve.
-
Cold atmospheric plasma to improve cannulation-site wound healing after extracorporeal life support
This trial will test whether adding cold atmospheric plasma (CAP) to standard wound care helps adults on extracorporeal life support heal cannulation-site wounds faster and with fewer infections.
-
PowerHeal Bioelectric Bandage for infected open wound recovery
This tests whether the PowerHeal™ Bioelectric Bandage helps adults with infected traumatic wounds heal faster and clear infection better than standard dressings.
-
Comparing wound infection risk after open versus laparoscopic gallbladder removal
This will see if open or laparoscopic gallbladder removal causes more wound infections in adults 18–65 with symptomatic gallstones.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.